Related Experiment Videos

Distal nephron renal tumors: microsatellite allelotype

T J Polascik1, P Cairns, J I Epstein

  • 1James Buchanan Brady Urological Institute, Johns Hopkins University Medical Institutions, Baltimore, Maryland 21287-6101, USA.

Cancer Research
|April 15, 1996
PubMed

Insights

Molecular analysis reveals distinct genetic changes in kidney tumors. Collecting duct carcinomas and renal oncocytomas show specific chromosomal alterations, differing from proximal tubule cancers.

Area of Science:

  • Nephrology
  • Oncology
  • Molecular Biology

Background:

  • Renal tumors arise from the nephron's epithelial lining, with proximal tubule cancers (clear cell carcinomas) being well-studied.
  • Tumors originating from other renal tubular segments, such as collecting duct carcinomas and oncocytomas, have poorly understood molecular underpinnings.
  • Identifying common molecular lesions is crucial for understanding the development and progression of these less-characterized renal tumors.

Purpose of the Study:

  • To investigate common molecular lesions in renal tumors originating from the collecting duct.
  • To compare the molecular characteristics of collecting duct carcinomas (CDCs) and renal oncocytomas.
  • To elucidate the distinct molecular events contributing to non-proximal tubule renal cancers.

Main Methods:

  • Detailed microsatellite allelotype analysis was performed on 18 collecting duct carcinomas and 13 renal oncocytomas.
  • Highly informative microsatellite markers were used across all autosomal arms to detect loss of heterozygosity (LOH).
  • Analysis focused on identifying chromosomal arm alterations specific to each tumor type.

Main Results:

  • Loss of heterozygosity (LOH) was observed on multiple chromosomal arms in both CDCs and oncocytomas.
  • Significant LOH was found in CDCs on 1q (57%), 6p (45%), 8p (40%), and 21q (40%).
  • Renal oncocytomas showed high LOH rates on 1p (57%), 1q (30%), 8p, 14q, 19q, and 21q; LOH on 3p was infrequent in both tumor types.

Conclusions:

  • The molecular events driving the development of distal nephron tumors (CDCs and oncocytomas) are distinct from those in proximal tubule renal cancers.
  • Specific chromosomal alterations, such as LOH on 1q, 6p, 8p, and 21q in CDCs, and 1p in oncocytomas, characterize these tumor types.
  • This study provides insights into the molecular etiology of non-proximal tubule renal tumors, differentiating them from clear cell renal cell carcinomas.

Related Concept Videos